Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

ITMN has upside surprise

|Includes:InterMune, Inc. (ITMN)

All the bad news has been out.  FDA disapproval on request for more info, while review panel recommended the drug to be approved.  It's an indication that FDA returning it to the applicant just because application is incomplete.  That happens a lot when a company rush to get a study approved, without providing all the write-ups.  Knowing that, i am waiting for ITMN to drop a little more so I can buy.  As long sellers are done, I want to get in as a buyer.   

Stocks: ITMN